According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$2.10. In 2022 the company made an earnings per share (EPS) of HK$0.93 a decrease over its 2021 EPS that were of HK$4.67.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$2.11 | 126.62% |
2022 | HK$0.93 | -80% |
2021 | HK$4.67 | 39.53% |
2020 | HK$3.34 | -80.18% |
2019 | HK$16.87 | 334% |
2018 | HK$3.89 | -247.06% |
2017 | -HK$2.64 | -19.05% |
2016 | -HK$3.27 | -55.32% |
2015 | -HK$7.31 | -347.37% |
2014 | HK$2.95 | -156.72% |
2013 | -HK$5.21 | -31.63% |
2012 | -HK$7.62 | 172.22% |
2011 | -HK$2.80 | -238.46% |
2010 | HK$2.02 | -119.7% |
2009 | -HK$10.26 | -31.61% |
2008 | -HK$15.01 | -31.32% |
2007 | -HK$21.85 | -99.27% |
2006 | -HK$3,013 | 36045.14% |
2005 | -HK$8.34 |